Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Healthcare and Medicine...+1Chemical Products
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient naloxegol, ATC A06AH03 (obo) for the period 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Albendazol, Atc P02ca03 (obg) Für Die Zeit 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Fesoterodin, Atc G04bd11 (obg) Für Die Zeit 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Chemical Products
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient albendazole, ATC P02ca03 (obg) for the period 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient lisdexamfetamine, ATC N06ba12 (obg) for the period 01.08.24 - 31.07.25 (plus extension option 1x12 months)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient bimatoprost + timolol (exclusively Edo), ATC S01ed62 (obo) for the period 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient ustekinumab, Atc L04ac05 (obo) for the period 01.08.2024 - 31.07.2025 (plus extension option 1x12 months)

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountEUR 1 (USD 1)
Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Pegvisomant, Atc H01ax01 (obo) Für Die Zeit 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient clonazepam, ATC N03ae01 (obg) for the period 01.08.2024 - 31.07.2026

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Closing Date5 Jun 2026
Tender AmountRefer Documents 
Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient olanzapine (excl. Dafo. For the production of a depot - ISU, ATC N05AH03 (obo) FDZ 01.08.24 - 31.07.26
131-140 of 331 active Tenders